Clinical Report: Management of Parotid Gland Oncocytoma

Overview

This report discusses a case of parotid oncocytoma managed with postoperative radiotherapy to improve local control and reduce recurrence risk. The findings highlight the importance of multidisciplinary decision-making in treatment planning.

Background

Parotid oncocytoma is a rare benign neoplasm that poses challenges in management, particularly in cases with multifocal lesions or incomplete excision. Surgical excision is the standard treatment, but recurrence rates can increase significantly in these scenarios. Postoperative radiotherapy may serve as an effective adjunct to improve outcomes in select patients.

Data Highlights

No numerical data or trial data presented in the article.

Key Findings

• Parotid oncocytoma is a rare benign neoplasm, constituting 0.1% to 1.5% of salivary gland tumors.
• The standard treatment is surgical excision, with a reported recurrence rate of approximately 2.7%.
• Postoperative radiotherapy can improve local control and reduce recurrence rates in cases with multifocal lesions or incomplete excision.
• A 61-year-old male case study demonstrated the use of adjuvant radiotherapy following parotidectomy.
• Multidisciplinary team discussions are crucial in determining the need for postoperative radiotherapy.

Clinical Implications

Clinicians should consider the potential benefits of adjuvant radiotherapy in patients with parotid oncocytoma who are at high risk for recurrence. A thorough evaluation and multidisciplinary approach are essential for optimizing patient outcomes.

Conclusion

This case underscores the role of postoperative radiotherapy in managing parotid oncocytoma, particularly in patients with increased recurrence risk. Further studies may help refine treatment protocols for this rare neoplasm.

Related Resources & Content

1. Salivary Gland Oncocytomas. A Systematic Review - PMC, 2024 -- Salivary Gland Oncocytomas
2. Radiation Therapy After Surgical Resection Improves Outcomes for Patients With Recurrent Pleomorphic Adenoma - PMC, 2021 -- Radiation Therapy for Pleomorphic Adenoma
3. The ASCO Post — Radiotherapy Not Helpful in Early-stage Parotid Acinic Cell Cancer
4. Acta Neuropathologica — Diagnostic Challenges in Oligodendroglial Tumors Exhibiting Ganglioglioma-like Features
5. Frontiers in Oncology — Complete Response of a Giant Metastatic Neck Mass in Tonsillar Squamous Cell Carcinoma Achieved with Radiotherapy Combined with Immunotherapy: A Case Report
6. Journal of Neuro-Oncology — Stereotactic Radiosurgery for the Treatment of Pituitary Neuroendocrine Tumors
7. Radiotherapy Not Helpful in Early-stage Parotid Acinic Cell Cancer
8. CT Features of Parotid Gland Oncocytomas: A Study of 10 Cases and Literature Review - PMC
9. Salivary Gland Oncocytomas. A Systematic Review - PMC
10. Recommendations for using radiotherapy
11. Radiation Therapy After Surgical Resection Improves Outcomes for Patients With Recurrent Pleomorphic Adenoma - PMC
12. Pleomorphic Adenoma - StatPearls - NCBI Bookshelf